BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study
BriaCell Therapeutics Corp. Study to evaluate the effects of Bria-OTS™ in combination with anti-PD-1 antibody tislelizumab, in advanced, late stage, heavily pretreated metastatic breast cancer. PH...